Healthy elderly subjects
Conditions
Interventions
None listed
Sponsors
Meiji Co., Ltd.
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: 1) Subjects giving written informed consent 2) Subjects who participate in the clinical trial (UMIN ID: UMIN000044496) 3) Participants in the project for evaluation of cognitive function using tablet devices in Obihiro City, Hokkaido
Exclusion criteria
Exclusion criteria: None
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| TDAS, Cognitive function assessment device with line of sight, MMSE, MoCA, Plasma BDNF concentration, Plasma NGF concentration, Plasma omega 3-fatty acids concentration (DHA and EPA), Plasma DHA concentration, Plasma EPA concentration, CRP concentration, Lean body mass, BMI, SMI, Subjective health status, Frequency of going out | — |
Countries
Japan
Contacts
Public ContactYoshimura Aya
Meiji Co., Ltd. R & D Division
Outcome results
None listed